2024
2023
- Heat, health and human genetics
- Human involvement in AI-driven digital pathology pathways: ethical and legal considerations
- Workshop report on adopting a risk tool for stratification and predictive prevention of oesophageal cancer
- Are synthetic health data ‘personal data’?
- Evaluation of polygenic score applications
2022
2021
- Control of patient information in the COVID-19 era
- Implementing polygenic scores for cardiovascular disease into NHS Health Checks
- The ethical and legal framework for a Genomics England and Sano Genetics participant engagement platform
- Polygenic scores and clinical utility
- Visual identifiers in the care of people with dementia
2020
- Citizen generated data and health: predictive prevention of disease
- Personalising breast cancer prevention – bridging the gap between research and policy
- The GDPR and genomic data
- Artificial intelligence for genomic medicine
- Black box medicine and transparency
2019
- Our healthy future – a series of reports incl.
- Algorithms as medical devices
- Regulating algorithms in healthcare: the GDPR and IVDR in practice
- Polygenic scores, risk and cardiovascular disease
- Personalising prevention for breast cancer
- Dementia risk prediction
2018
- The personalised medicine technology landscape
- Genomics in mainstream clinical pathways
- Identification and genomic data
2017
- Personalised prevention in breast cancer – the policy landscape
- Developing effective ctDNA testing services for lung cancer
- Linking and sharing routine health data for research
- Variant classification and interpretation – workshop report
- Whole exome sequencing in clinical genetics – a health economic evaluation
- Personalised healthcare: bringing the future into focus
- Delivering improved access to genetic testing in epithelial ovarian cancer
2016
2015
- Data sharing to support UK clinical genetics and genomics services
- Pathogen Genomics Into Practice
- Genetic screening programmes: an international review of assessment criteria
2014
- Realising Genomics in Clinical Practice
- A guide to the investigation of intellectual disability and developmental delay in East Anglia
- Enhanced Genetic Services Project
- Stratified Screening for Cancer
2013
- Realising Genomics in Clinical Practice (interim report)
- Managing incidental and pertinent findings from WGS in the 100,000 Genomes Project
- Genomics of obesity
2012
2011
- Epidemiology, risk and causation
- Next steps in the sequence
- Quality standards in risk prediction
- Genetics and mainstream medicine: service development and integration
2010
- Public health in an era of genome-based and personalised medicine
- Expanded newborn screening
- Independent response to House of Lords Science and Technology Committee Genomic Medicine report
- Predicting the risk of coronary heart disease with conventional, genetic and novel molecular biomarkers
2009
- Tay Sachs Disease carrier screening in the Ashkenazi Jewish population
- Heart to Heart: inherited cardiovascular conditions services
- Cell-free fetal nucleic acids for non-invasive prenatal diagnosis
2008
- Evidence and evaluation: Building public trust in genetic tests for common diseases
- Genetic ophthalmology in focus
- The evaluation of diagnostic laboratory tests and complex biomarkers
2007
- The evaluation of clinical validity and clinical utility of genetic tests
- Family history as a risk factor for common, complex disease
- Moving beyond ACCE: An expanded framework for genetic test evaluation
2006
- Assessment of the Human Tissue Act
- Evaluation of array-CGH for chromosomal abnormalities in clinical practice
- Learning disability: the interface with genetics
- Biomarkers in familial colorectal cancer screening
- Ethical legal and social issues in stem cell research and therapy – 2nd edition